Abstract
Liver, being the second largest organ, maintains homeostasis by undergoing a number of risk factors that include alcohol, drugs, environmental pollutants, and radiation. All these factors are capable of inducing oxidative stress by generating free radicals that eventually result in various forms of severe liver diseases. In this chapter, the consequences of oxidative stress are studied, along with its pathophysiology, its effects on organelles, physiological alterations, and the common diseases that occur due to oxidative stress. The progression of various liver diseases primarily involves lipid peroxidation, deoxyribonucleic acid (DNA) damage, signaling of inflammatory mediators, and ultimately generation of free radicals. The inarguable role of prooxidants in hepatic pathogenesis can be evidenced by an increase in the levels of biomarkers of oxidative stress, namely, malondialdehyde (MDA) and 4-hydroxynonenal (4-HNE), to name a few. These markers are paralleled by utilizing endogenous antioxidant mechanisms, thus decreasing the levels of superoxide dismutase (SOD), glutathione peroxidase (GPx), catalase (CAT), and glutathione (GSH).
This challenge was overcome by a diverse and rapid development in the field of biomarkers and antioxidants. Newer advances in the field of biomarkers outlined strategies to identify diseases at an early stage so that the treatment procedure could be both clinically useful and cost-effective. Advanced research on antioxidants, to treat liver disease, resulted in the emergence of natural substances that contain common natural herbal extracts, vitamins, and other compounds. Antioxidant use, either as a single compound or in combination, has become key molecules today for counteracting our stressed system and to achieve healthy homeostasis. However, new research should be carried out at cellular and molecular pharmacology levels in combination with drug targeting systems so as to get innovative ideas for the therapeutics of hepatic disease, which are not known enough.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Jones DP (2006) Redefining oxidative stress. Antioxid Redox Signal 8:1865–1879
Muriel P (2007) Some experimental models of liver damage. In: Sahu SC (ed) Hepatotoxicity: from genomics to in vitro and in vivo models. Wiley, West Sussex, p 119e137
Halina CL, Agata M (2014) Oxidative stress as a crucial factor in liver diseases. World J Gastroenterol 20(25):8082–8091
Li AN, Li S, Zhang YJ, Xu XR, Chen YM, Li HB (2014) Resources and biological activities of natural polyphenols. Nutrients 6:6020–6047
Valente MJ, Carvalho F, Bastos M, de Pinho PG, Carvalho M (2012) Contribution of oxidative metabolism to cocaine-induced liver and kidney damage. Curr Med Chem 19:5601–5606
Nguyen V, Huang J, Doan V, Lin X, Tang X, Huang Y, Tang A, Yang X, Huang R (2015) Hepatoprotective effects of Yulangsan polysaccharide against nimesulide-induced liver injury in mice. J Ethnopharmacol 172:273–280
Dornas WC, de Lima WG, dos Santos RC, Guerra JF, de Souza MO, Silva M, Souza e Silva L, Diniz MF, Silva ME (2013) High dietary salt decreases antioxidant defences in the liver of fructose-fed insulin-resistant rats. J Nutr Biochem 24:2016–2022
Skowronska M, Albrecht J (2013) Oxidative and nitrosative stress in ammonia neurotoxicity. Neurochem Int 62:731–737
Paik YH, Kim J, Aoyama T, De Minicis S, Bataller R, Brenner DA (2014) Role of NADPH oxidases in liver fibrosis. Antioxid Redox Signal 20:2854–2872
Elias-Miro M, Jiménez-Castro MB, Rodés J, Peralta C (2013) Current knowledge on oxidative stress in hepatic ischemia/reperfusion. Free Radic Res 47:555–568
Ozer J, Ratner M, Shaw M, Bailey W, Schomaker S (2008) The current state of serum biomarkers of hepatotoxicity. Toxicology 245:194–205
Casas-Grajales S, Muriel P (2015) Antioxidants in liver health. World J Gastrointest Pharmacol Ther 6:59–72
Reiter RJ, Tan DX, Mayo JC, Sainz RM, Leon J, Czarnocki Z (2003) Melatonin as an antioxidant: biochemical mechanisms and pathophysiological implications in humans. Acta Biochim Pol 50:1129–1146
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Singh, L. et al. (2020). Oxidative Stress in Liver Diseases. In: Maurya, P., Dua, K. (eds) Role of Oxidative Stress in Pathophysiology of Diseases. Springer, Singapore. https://doi.org/10.1007/978-981-15-1568-2_13
Download citation
DOI: https://doi.org/10.1007/978-981-15-1568-2_13
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-15-1567-5
Online ISBN: 978-981-15-1568-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)